Insights

Niche Antibiotics Discuva specializes in next generation antibiotics targeting drug-resistant pathogens, signaling opportunities to partner on early-stage discovery programs or co-development with pharma companies seeking innovative antimicrobial pipelines.

Cambridge Bio Hub Headquartered in Cambridge UK with a focused team size, offering potential for collaboration with nearby academic and biotech networks, contract research, and joint ventures to accelerate lead identification and preclinical work.

Acquisition History Formerly acquired by Summit Therapeutics, indicating a precedent for exit-ready assets and potential for strategic divestment or licensing discussions with buyers looking to bolster antimicrobial portfolios.

Limited Revenue Current revenue under one million suggests a need for partnership models emphasizing upfront research funding, milestone-based payments, and co-development arrangements to de-risk investment.

Tech & Stack Proprietary genomic-based discovery methods complemented by common tech stack (WordPress, Microsoft 365, PHP) imply receptiveness to white-label or platform-enabled collaboration tools and data-sharing arrangements to streamline joint R&D.

Similar companies to Discuva

Discuva Tech Stack

Discuva uses 5 technology products and services including WordPress, Microsoft 365, jQuery, and more. Explore Discuva's tech stack below.

WordPress
Content Management System
Microsoft 365
Email
jQuery
Javascript Libraries
PHP
Programming Languages
GoDaddy
Web Hosting

Media & News

Summit Corporation acquired Discuva for $13.4M on Jan 1st '18.
In 2018 he engineered the disposal of Discuva Ltd to Oxford-based, Nasdaq-quoted Summit Therapeutics in a £10m cash plus shares deal.
Jun 03, 2020 | www.businessweekly.co.uk

Discuva's Email Address Formats

Discuva uses at least 1 format(s):

Discuva Email Formats	Example	Percentage
First.Last@discuva.com	John.Doe@discuva.com	86%
FLast@discuva.com	JDoe@discuva.com	14%

Frequently Asked Questions

What is Discuva's phone number?

You can contact Discuva's main corporate office by phone at

+44-1223-39****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Discuva's official website and social media links?

Discuva's official website is discuva.com and has social profiles on LinkedIn.

How much revenue does Discuva generate?

As of July 2026, Discuva's annual revenue is estimated to be <$1M.

What is Discuva's NAICS code?

Discuva's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Discuva have currently?

As of July 2026, Discuva has approximately 11 employees across 1 continents, including Europe. Key team members include Director: D. W.Director: E. R.Director: U. N.. Explore Discuva's employee directory with LeadIQ.

What industry does Discuva belong to?

Discuva operates in the Pharmaceuticals industry.

What technology does Discuva use?

Discuva's tech stack includes WordPressMicrosoft 365jQueryPHPGoDaddy.

What is Discuva's email format?

Discuva's email format typically follows the pattern of First.Last@discuva.com. Find more Discuva email formats with LeadIQ.

When was Discuva founded?

Discuva was founded in 2009.

Discuva

Q: What is Discuva's official website and social media links?

Discuva's official website is discuva.com. Discuva has social profiles on LinkedIn.

Q: How many employees does Discuva have currently?

Discuva has approximately 11 employees.

Q: What industry does Discuva belong to?

Discuva operates in the Pharmaceuticals industry.

Q: What technology does Discuva use?

Discuva's tech stack includes GoDaddy, PHP, WordPress, jQuery, Microsoft 365.

Q: What is Discuva's NAICS code?

Discuva's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

PharmaceuticalsEngland, United Kingdom11-50 Employees

Discuva is a Cambridge, England-based company pursuing next-generation approaches to antibiotic discovery. It was established to address gaps in the current treatment of infectious diseases by developing targeted antibiotics aimed at newly emerging and drug-resistant pathogens. The company bases its work on methods that have emerged from advances in genomic technologies to guide its discovery efforts.

Discuva positions itself to partner with pharmaceutical and biotechnology organizations seeking novel antimicrobial therapies. Its leadership draws on experience from the pharma and biotech sectors, supported by a strong scientific pedigree.